Spots Global Cancer Trial Database for Prevention of Chest Pain in Chemo-treated Cancer Patients
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Prevention of Chest Pain in Chemo-treated Cancer Patients
Official Title: Prevention of CArdioToxic-related CHest Pain in Cancer Patients Treated With 5-fluorouracil
Study ID: NCT03486340
Interventions
Study Description
Brief Summary: This is a prospective, exploratory, randomised clinical trial. Patients with diagnosed cancer that are to be treated with 5-fluorouracil (5-FU) will be randomised into standard oncological treatment or a cardiological assessment prior to the 5-FU treatment. The investigators hypothesize that aggressive management of ischemic risk factors in asymptomatic patients will reduce the number of hospitalisations and investigations for acute coronary syndrome during and after 5-FU treatment and that patients with high coronary artery calcium scores are more likely to experience chest pain during the treatment with 5-FU.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Departments of Oncology and Medicine, Vejle Hospital, Vejle, , Denmark
Contact Details
Name: Vibeke B Hansen, MD, PhD
Affiliation: Vejle Hospital
Role: PRINCIPAL_INVESTIGATOR
Name: Lars H Jensen, MD, PhD
Affiliation: Department of Oncology, Vejle Hospital, Denmark
Role: STUDY_CHAIR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
